Wird geladen...
Predicting long‐term clinical stability in amyloid‐positive subjects by FDG‐PET
Imaging biomarkers can be used to screen participants for Alzheimer's disease clinical trials. To test the predictive values in clinical progression of neuropathology change (amyloid‐PET) or brain metabolism as neurodegeneration biomarker ([18F]FDG‐PET), we evaluated data from N = 268 healthy c...
Gespeichert in:
| Veröffentlicht in: | Ann Clin Transl Neurol |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6562030/ https://ncbi.nlm.nih.gov/pubmed/31211176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.782 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|